Pengli Li

Associate
Full contact info

Experience

Core Scientific to Combine With SPAC Power & Digital Infrastructure Acquisition Corp.

August 18, 2021

Cooley advised Core Scientific, a carbon-neutral vertically integrated blockchain infrastructure and mining company, on its merger agreement with special purpose acquisition company (SPAC) Power & Digital Infrastructure Acquisition Corp. The transaction values the combined company, which will be called Core Scientific Inc. and listed on the Nasdaq, at an implied pro forma fully diluted enterprise value of approximately $4.3 billion. Partners Daniel Peale, David Silverman and Nicolas Dumont led the Cooley team advising Core Scientific.

Read more

Related contacts

Daniel Peale
Partner, Washington, DC
David Silverman
Partner, New York
Nicolas H.R. Dumont
Partner, New York
Richard G.S. Lee
Associate, Washington, DC
Eileen Marshall
Partner, Washington, DC
David Safren
Associate, New York
Pengli Li
Associate, Boston
Todd Gluth
Partner, San Diego
Howard Morse
Partner, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Nancy Wojtas
Senior Counsel, Palo Alto
David Walsh
Partner, Reston
Calvin Lee
Associate, New York
Christian Lee
Associate, San Francisco

Related Practices & Industries

Finch Therapeutics – $128 Million IPO

April 8, 2021

Cooley advised Finch Therapeutics on its $127.5 million initial public offering of 7,500,000 shares of common stock. Finch Therapeutics, whose securities now trade on the Nasdaq Global Select Market under the symbol FNCH, is a clinical-stage microbiome therapeutics company. Partners Div Gupta and Ryan Sansom led the Cooley team.

Related contacts

Div Gupta
Partner, New York
Ryan Sansom
Partner, Boston
Courtney Thorne
Partner, Boston
Trey Reilly
Associate, New York
Michael Bruno
Associate, New York
Pengli Li
Associate, Boston

Related Practices & Industries

Advises Anchiano Therapeutics Ltd on its reverse-merger with Chemomab

February 26, 2021

Cooley advised Anchiano Therapeutics Ltd, a preclinical biopharmaceutical company developing targeted therapies to treat cancer in areas of significant clinical need, on its reverse-merger with Chemomab.

Related contacts

Josh Kaufman
Partner, New York
Mark Jones
Associate, London
Pengli Li
Associate, Boston

Related Practices & Industries

Repare Therapeutics - $253 Million IPO

June 23, 2020

Cooley advised Repare Therapeutics on its $253 million initial public offering of 12,650,000 shares of common stock, including full exercise of the underwriters’ option to purchase additional shares. Repare Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol “RPTX”, is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. Partners Div Gupta, Ryan Sansom and Marc Recht led the Cooley team.

Related contacts

Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Ryan Sansom
Partner, Boston
Courtney Thorne
Partner, Boston
Trey Reilly
Associate, New York
Pengli Li
Associate, Boston
Ryan Sonberg
Associate, Boston

Related Practices & Industries

Datadog – $745 Million IPO

September 19, 2019

Cooley advised Datadog on its $745.2 million initial public offering of 24,000,000 shares of Class A common stock. Datadog, whose securities now trade on the Nasdaq Global Select Market under the symbol “DDOG,” is a monitoring and analytics platform for developers, IT operations teams and business users in the cloud age. Partners Jodie Bourdet and Nicole Brookshire led the Cooley team.

Read more

Related contacts

Jodie Bourdet
Partner, San Francisco
Evan Leitner
Associate, New York
Pengli Li
Associate, Boston

Related Practices & Industries

View more